Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

© 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved. 

1 Introduction

This document describes the CDISC implementation of the Hamilton Depression Rating Scale 17-Item (HAMD 17) instrument.

...

The CDISC Intellectual Property Policy can be found on the CDISC website at: https://www.cdisc.org/about/bylaws.

1.1 Representations and Warranties, Limitations of Liability, and Disclaimers

This document is a supplement to the SDTMIG for Human Clinical Trials and is covered under Appendix F of that document, which describes representations, warranties, limitations of liability, and disclaimers. Please see Appendix F of the SDTMIG for a complete version of this material.

...

Although the United States Food and Drug Administration (US FDA) has provided input with regard to this supplement, this input does not constitute US FDA endorsement of any particular instrument.

2 Copyright Status

CDISC believes this instrument to be in the public domain, but you should perform your own assessment. CDISC has included the HAMD 17 in the CDISC library of QRS data standards supplements. Hence, CDISC developed RSTESTCD and RSTEST for each item based on the actual text on the instrument. There may be many versions of this instrument. CDISC has chosen to use this version as the data standard.

...

  • Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56–62.

  • Development of a Rating Scale for Primary Depressive Illness BY MAX HAMILTON, Department of Psychiatry, University of Lee, Brit. J. soc. Clin. Psychol. (1967), 6, pp. 278-296, Printed in Great Britain.

  • Guy W, ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: US Department of Health, Education, and Welfare, 1976.
  • The Hamilton Rating Scale for Depression: The making of a ‘‘gold standard’’ and the unmaking of a chronic illness, 1960–1980.

  • Assessment Scales in Depression, Mania and Anxiety, Raymond W Lam, MD, FRCPC, Erin E. Michalak, PhD, Richard P Swinson, MD, FRCPsych, FRCPC, Copyright 2005 Taylor & Francis, an imprint of the Taylor & Francis Group.

3 The RS Domain Model

3.1 Assumptions for the RS Domain Model

All assumptions and business rules described in the SDTMIG RS domain are applicable to this supplement. Additional assumptions specific to the HAMD 17 are listed below.

...

  1. The scale points include a numeric rating (0-2, 0-3, or 0-4) and a definition of what is represented by the rating (e.g., 0 = "Absent.", 4 = "Incapacitating."). For the HAMD 17, RSORRES is populated with the text description while the numeric rating is represented in the standardized character and numeric result variables RSSTRESC and RSSTRESN.

  2. The time period of evaluation for the HAMD 17 is populated in the RSEVLINT variable in ISO 8601 format when the evaluation interval can be precisely described as duration. The evaluation interval for the HAMD 17 is determined based on the sponsor's stated evaluation interval.

  3. The HAMD 17 instrument includes a total score that is considered as captured data on the CRF and is not considered as derived in the example below. This score may be submitted in SDTM or derived in the Analysis Data Model (ADaM).

    1. If operationally defined by the sponsor, it is the sponsor's responsibility to set the --DRVFL flag based on their eCRF process to derive subtotals and total scores. An investigator-derived score will be considered a captured score and not flagged. When subtotal and total scores are derived by the sponsor, the derived flag (--DRVFL) is set to "Y". However, when the subtotal and total scores are received from a central provider or vendor, the value would go into --ORRES and --DRVFL would be null (see SDTMIG Section 4.1.8.1, Origin Metadata for Variables).

    2. if scores are received by the sponsor, it is recommended that they are submitted to SDTM and verified in ADaM.
  4. Item 16 contains 2 components: Part A, which is loss of weight according to the patient, and Part B, which is loss of weight according to weekly measurements. Only 1 of these items is answered when administering the HAMD 17 instrument. A record is created in rs.xpt for all items. The unanswered component is considered as a logically skipped item in the data and is represented as follows:

    1. RSSTAT = "NOT DONE".

    2. RSREASND = "LOGICALLY SKIPPED ITEM".

    3. RSORRES, RSSTRESC, and RSSTRESN are set to null.

  5. Terminology

    1. RSCAT, RSTESTCD, and RSTEST values are included in CDISC Controlled Terminology.

    2. A full list of value sets for the result fields is provided in Section 4, SDTM Mapping Strategy.

3.2 Example for the HAMD 17 RS Domain Model

The HAMD 17 example below shows the terminology used to implement the instrument in the RS domain. This example shows the data for 1 subject collected at the baseline visit and a visit 2 represented as not being collected for the HAMD 17 instrument. The example uses CDISC Controlled Terminology for RSTESTCD, RSTEST, and RSCAT. All original results are represented with preferred terminology in RSORRES. This result is then transformed into the standard numeric score in RSSTRESN and a character representation of the standard numeric score in RSSTRESCThe sponsor's evaluation interval for the example is the past week (RSEVLINT = "-P1W").

...

Dataset wrap
Namers
Rowcaps
Row 16:Represents item 16 Part A when the subject answered the weight loss according to the patient.
Row 17:

Represents item 16 Part B as a logically skipped item when the 16 Part A item is answered.

Row 19:Represents the total score. All total scores are considered as captured data unless the sponsor operationally derives it via an EDC system.
Rows 20-38:Show the subject was not evaluated on this instrument at visit 2. Because the reason for not completing the visit was not collected, no date is assumed for when the visit would have occurred.
Dataset2
ROWSTUDYIDDOMAINUSUBJIDRSSEQRSTESTCDRSTESTRSCATRSORRESRSSTRESCRSSTRESNRSSTATRSREASNDRSLOBXFLVISITNUMRSDTCRSEVLINT
1STUDYXRS2324-P00011HAMD101HAMD1-Depressed MoodHAMD 17Absent.00

Y12019-11-16-P1W
2STUDYXRS2324-P00012HAMD102HAMD1-Feelings of GuiltHAMD 17Self reproach, feels he/she has let people down.11

Y12019-11-16-P1W
3STUDYXRS2324-P00013HAMD103HAMD1-SuicideHAMD 17Ideas or gestures of suicide.33

Y12019-11-16-P1W
4STUDYXRS2324-P00014HAMD104HAMD1-Insomnia Early - Early NightHAMD 17No difficulty falling asleep.00

Y12019-11-16-P1W
5STUDYXRS2324-P00015HAMD105HAMD1-Insomnia Middle - Middle NightHAMD 17No difficulty.00

Y12019-11-16-P1W
6STUDYXRS2324-P00016HAMD106HAMD1-Insomnia Early Hours -MorningHAMD 17No difficulty.00

Y12019-11-16-P1W
7STUDYXRS2324-P00017HAMD107HAMD1-Work and ActivitiesHAMD 17No difficulty.00

Y12019-11-16-P1W
8STUDYXRS2324-P00018HAMD108HAMD1-RetardationHAMD 17Slight retardation during the interview.11

Y12019-11-16-P1W
9STUDYXRS2324-P00019HAMD109HAMD1-AgitationHAMD 17Fidgetiness.11

Y12019-11-16-P1W
10STUDYXRS2324-P000110HAMD110HAMD1-Anxiety PsychicHAMD 17No difficulty.00

Y12019-11-16-P1W
11STUDYXRS2324-P000111HAMD111HAMD1-Anxiety SomaticHAMD 17Moderate.22

Y12019-11-16-P1W
12STUDYXRS2324-P000112HAMD112HAMD1-Somatic Symptoms GastrointestinalHAMD 17None.00

Y12019-11-16-P1W
13STUDYXRS2324-P000113HAMD113HAMD1-General Somatic SymptomsHAMD 17None.00

Y12019-11-16-P1W
14STUDYXRS2324-P000114HAMD114HAMD1-Genital SymptomsHAMD 17Mild.11

Y12019-11-16-P1W
15STUDYXRS2324-P000115HAMD115HAMD1-HypochondriasisHAMD 17Not present.00

Y12019-11-16-P1W
16STUDYXRS2324-P000116HAMD116AHAMD1-Loss of WT According to PatientHAMD 17Definite (according to patient) weight loss.22

Y12019-11-16-P1W
17STUDYXRS2324-P000117HAMD116BHAMD1-Loss of WT According to WK MeasHAMD 17


NOT DONELOGICALLY SKIPPED ITEMY12019-11-16-P1W
18STUDYXRS2324-P000118HAMD117HAMD1-InsightHAMD 17Denies being ill at all.22

Y12019-11-16-P1W
19STUDYXRS2324-P000119HAMD118HAMD1-Total ScoreHAMD 17131313

Y12019-11-16-P1W
20STUDYXRS2324-P000120HAMD101HAMD1-Depressed MoodHAMD 17


NOT DONE

2

21STUDYXRS2324-P000121HAMD102HAMD1-Feelings of GuiltHAMD 17


NOT DONE

2

22STUDYXRS2324-P000122HAMD103HAMD1-SuicideHAMD 17


NOT DONE

2

23STUDYXRS2324-P000123HAMD104HAMD1-Insomnia Early - Early NightHAMD 17


NOT DONE

2

24STUDYXRS2324-P000124HAMD105HAMD1-Insomnia Middle - Middle NightHAMD 17


NOT DONE

2

25STUDYXRS2324-P000125HAMD106HAMD1-Insomnia Early Hours -MorningHAMD 17


NOT DONE

2

26STUDYXRS2324-P000126HAMD107HAMD1-Work and ActivitiesHAMD 17


NOT DONE

2

27STUDYXRS2324-P000127HAMD108HAMD1-RetardationHAMD 17


NOT DONE

2

28STUDYXRS2324-P000128HAMD109HAMD1-AgitationHAMD 17


NOT DONE

2

29STUDYXRS2324-P000129HAMD110HAMD1-Anxiety PsychicHAMD 17


NOT DONE

2

30STUDYXRS2324-P000130HAMD111HAMD1-Anxiety SomaticHAMD 17


NOT DONE

2

31STUDYXRS2324-P000131HAMD112HAMD1-Somatic Symptoms GastrointestinalHAMD 17


NOT DONE

2

32STUDYXRS2324-P000132HAMD113HAMD1-General Somatic SymptomsHAMD 17


NOT DONE

2

33STUDYXRS2324-P000133HAMD114HAMD1-Genital SymptomsHAMD 17


NOT DONE

2

34STUDYXRS2324-P000134HAMD115HAMD1-HypochondriasisHAMD 17


NOT DONE

2

35STUDYXRS2324-P000135HAMD116AHAMD1-Loss of WT According to PatientHAMD 17


NOT DONE

2

36STUDYXRS2324-P000136HAMD116BHAMD1-Loss of WT According to WK MeasHAMD 17


NOT DONE

2

37STUDYXRS2324-P000137HAMD117HAMD1-InsightHAMD 17


NOT DONE

2

38STUDYXRS2324-P000138HAMD118HAMD1-Total ScoreHAMD 17


NOT DONE

2


4 SDTM Mapping Strategy

This section is used for reference regarding the CRF data capture and to understand the alignment of the instrument to the SDTM RS domain. It also provides guidance on how the result variables (RSORRES, RSSTRESC, and RSSTRESN) should be populated.

...